[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581224":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":22,"responsibleParty":32,"collaborators":7,"id":36,"slug":7,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":7,"eligibilityCriteria":41,"healthyVolunteers":37,"sex":42,"minAge":43,"maxAge":7,"enrollmentInfo":44,"targetDuration":7,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":51,"overallStatus":53,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Alaa El-Din Abdel Moneim El-Sayed, Doctor","STUDY_CHAIR",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Marlien Wiliam Fayez, Resident doctor","CONTACT","01156900472","Marlienwilliam1@gmail.com",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"Mai Mostafa Mohamed, Doctor","01223971678","Mai_heamatology@aun.edu.eg",[23],{"facility":5,"status":7,"city":24,"state":7,"zip":7,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":7},"Asyut","Egypt",{"type":27,"coordinates":28},"Point",[29,30],31.18368,27.18096,{"lat":30,"lon":29},{"type":33,"investigatorFullName":34,"investigatorTitle":35,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Marline Wiliam Fayez Abdel-Shahid","Resident Doctor","100581224",false,"NCT06847529","Systemic Inflammatory Markers in B-cell Neoplasm","Systemic Inflammatory Markers As a Prognostic Index for B-cell Neoplasm , Single Center Experience .","Inclusion Criteria:\n\n* Individuals newly diagnosed with B-cell neoplasms, including:\n* Burkitt's lymphoma (BL)\n* Chronic lymphocytic leukemia (CLL)\n* Diffuse large B-cell lymphoma (DLBCL)\n* Follicular lymphoma (FL)\n* Hairy cell leukemia (HCL)\n* Splenic B-cell lymphoma\u002Fleukemia with prominent nucleoli (SBLPN)\n* High-grade B-cell lymphoma (HGBL)\n* Lymphoplasmacytic lymphoma (LPL)\u002FWaldenström macroglobulinemia\n* Mantle cell lymphoma (MCL)\n* Splenic marginal zone lymphoma (MZL)\n* Monoclonal B-cell lymphocytosis (MBL)\n* Multiple myeloma (plasma cell myeloma)\n* Monoclonal gammopathy of undetermined significance (MGUS)\n* Age 18 years or older.\n\nExclusion Criteria:\n\n* Individuals previously diagnosed with B-cell neoplasms.\n* Individuals younger than 18 years.","ALL","18 Years",{"count":45,"type":46},70,"ESTIMATED","OBSERVATIONAL","This study was to evaluate the role of systemic inflammatory markers in predicting outcome for patients with B cell neoplasm",[50],"B-cell Neoplasm",[52],"Systemic inflammatory markers as a prognostic index","NOT_YET_RECRUITING","2025-03-09",{"date":56,"type":57},"2025-03-12","ACTUAL",{"date":59,"type":46},"2025-03-22",{"date":61,"type":46},"2025-12-30",{"name":5,"class":6},1]